11-615011-A-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001572.5(IRF7):c.184-4T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.272 in 1,542,720 control chromosomes in the GnomAD database, including 61,954 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001572.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF7 | NM_001572.5 | c.184-4T>A | splice_region_variant, intron_variant | ENST00000525445.6 | NP_001563.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF7 | ENST00000525445.6 | c.184-4T>A | splice_region_variant, intron_variant | 5 | NM_001572.5 | ENSP00000434009.2 |
Frequencies
GnomAD3 genomes AF: 0.324 AC: 49144AN: 151834Hom.: 9250 Cov.: 35
GnomAD3 exomes AF: 0.248 AC: 40610AN: 163470Hom.: 5995 AF XY: 0.239 AC XY: 21478AN XY: 89888
GnomAD4 exome AF: 0.266 AC: 369688AN: 1390768Hom.: 52688 Cov.: 37 AF XY: 0.261 AC XY: 179109AN XY: 685460
GnomAD4 genome AF: 0.324 AC: 49196AN: 151952Hom.: 9266 Cov.: 35 AF XY: 0.313 AC XY: 23261AN XY: 74314
ClinVar
Submissions by phenotype
Immunodeficiency 39 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 11, 2023 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 07, 2020 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 59% of patients studied by a panel of primary immunodeficiencies. Number of patients: 56. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at